Article
Sodium-Glucose Cotransporter 2 Inhibitor Use Among Individuals Age <65 with Type 2…
ClinicoEconomics and Outcomes Research · 2022 · Glover S, Borrego ME, Ray GM, Roberts MH
Key facts
| Title | Sodium-Glucose Cotransporter 2 Inhibitor Use Among Individuals Age <65 with Type 2 Diabetes and Heart Failure with Reduced Ejection Fraction: A Cost–Benefit Analysis |
|---|---|
| First author | Glover S, Borrego ME, Ray GM, Roberts MH |
| Journal | ClinicoEconomics and Outcomes Research |
| Published | Jul 9, 2022 |
| DOI | 10.2147/CEOR.S361886 |
| Devices mentioned | 204042 |
At a glance
- 1–9 FDA submissions mentioned
- None Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1